State Street’s BioCardia BCDA Stock Holding History

State Street’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,400	Closed	-$8.55K	–	4366
2024 Q1	$8.55K	Hold	1,400	–	–	﹤0.01%	4332
2023 Q4	$13.9K	Hold	1,400	–	–	﹤0.01%	4375
2023 Q3	$8.97K	Hold	1,400	–	–	﹤0.01%	4516
2023 Q2	$56.1K	Hold	1,400	–	–	﹤0.01%	4388
2023 Q1	$41.2K	Hold	1,400	–	–	﹤0.01%	4551
2022 Q4	$43.9K	Hold	1,400	–	–	﹤0.01%	4587
2022 Q3	$41K	Hold	1,400	–	–	﹤0.01%	4696
2022 Q2	$31K	Hold	1,400	–	–	﹤0.01%	4811
2022 Q1	$43K	Hold	1,400	–	–	﹤0.01%	4816
2021 Q4	$41K	Hold	1,400	–	–	﹤0.01%	4724
2021 Q3	$66K	Buy	+1,400	New	+$68.6K	﹤0.01%	4617

Other funds holding BCDA

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Pingora Partners Wilson, Wyoming $171M AUM 60.67% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $6.54B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street's BCDA Position: Q2 2024 in Review

State Street sold out of BioCardia (BCDA) in Q2 2024, closing a stake of 1,400 shares — an estimated $8.55K sold.

State Street first reported a position in BCDA in Q3 2021 and held it in 11 quarters. The position peaked at $66K in Q3 2021. 10 funds tracked by Wall St. Rank hold BCDA as of Q2 2024.

State Street reported no remaining BioCardia position as of Q2 2024 after selling out during the quarter.
State Street sold 1,400 BioCardia shares in Q2 2024, an estimated $8.55K.
State Street first reported a position in BioCardia in Q3 2021 and held it in 11 quarters.
State Street's BioCardia position peaked at $66K in Q3 2021.
10 funds tracked by Wall St. Rank held BioCardia as of Q2 2024.

Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.